The panel that advises the California Division of Workers’ Compensation on evidence-based updates to the prescription drug formulary will discuss on Jan. 19 how to ensure that providers dispense the lowest-cost medications.
Pharmacy and Therapeutics Committee members will discuss “closing the high-cost drug loophole,” according to the agenda for the meeting.
According to slides that are included with agenda materials, loophole issues include relabeled drugs and compounded drugs that match listings in the Medical Treatment Utilization Schedule. These drugs often have prices ...
Comments